Anti-cancer drug price cap: Hospital and pharma stocks in focus; analysts see limited earnings impact

The impact on hospital chains is expected to be limited, according to Goldman Sachs, which said discussions with hospitals and industry participants suggest that most…

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)